Table I.
Study Characteristic | N (%) | |
---|---|---|
Publication Date | Before 1990 | 0 |
1990 – 1999 | 3 (9) | |
2000 – 2009 | 8 (24) | |
2010 - February 2019 | 22 (67) | |
Design* | Historically controlled (pre-post) | 26 (76) |
Retrospective cohort | 4 (12) | |
Prospective cohort | 2 (6) | |
Case-controlled | 2 (6) | |
Randomized controlled | 0 | |
Location | Europe | 18 (55) |
South America, Asia, or Africa | 8 (24) | |
North America | 5 (15) | |
Australia | 2 (6) | |
Number of patients (multidisciplinary care) | 0 – 24 | 0 (0) |
25 – 49 | 2 (6) | |
50 – 74 | 6 (18) | |
75 – 100 | 2 (6) | |
>100 | 18 (55) | |
Unknown | 5 (15) | |
Length of enrollment | Unknown | 12 (36) |
Until hospital discharge | 7 (21) | |
Until ulcer healed/major amputation | 5 (15) | |
Other | 9 (27) | |
Bias score | 22 – 25 (excellent) | 0 (0) |
17 – 21 (good) | 4 (12) | |
12 – 16 (fair) | 27 (82) | |
<12 (poor) | 2 (6) |
The n for Study Design totals 34, rather than 33, because one study used both a case-control design and a retrospective cohort design. We counted it in both categories.24